Pelthos Therapeutics Inc.
AED100.71
AED
Last updated on --.
24h volume7.65K
24h highest102.33 AED
24h lowest95.8286 AED
24h Price movement+2.85%
PTHS recent prices
24 Hours
+2.85%+AED2.791
30 days
+10.82%+AED9.843
60 days
+18.54%+AED15.31
90 days
+4.14%+AED4.003
Key data
Previous close97.9222 AED
Market cap346.09M AED
Volume7.65K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-54.5073 AED
Net income (FY)-189.49M AED
Revenue (FY)101.75M AED
Last report date14 May 2026
About Pelthos Therapeutics Inc.
HeadquartersDURHAM
Employees (FY)92.00
Revenue per employee (FY)1.11M AED
Net income per employee (FY)-2.06M AED
Listed onXASE
PTHS conversion tables
 |  |
|---|---|
| 0.5 PTHS | 50.35 AED |
| 1 PTHS | 100.71 AED |
| 5 PTHS | 503.56 AED |
| 10 PTHS | 1,007.13 AED |
| |
|---|---|
| 0.5 AED | 0.0049646 PTHS |
| 1 AED | 0.0099291 PTHS |
| 5 AED | 0.049646 PTHS |
| 10 AED | 0.099291 PTHS |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
PTHS is trading at AED100.71, +2.85% over the last 24 hours. Track live moves on the price chart at the top of this page.
The PTHS stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. PTHS is currently trading at AED100.71, +2.85% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on PTHS price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. PTHS's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from PTHS; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against PTHS's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Pelthos Therapeutics Inc.'s market cap is currently 346.09M AED. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume7.65K
24h highest102.33 AED
24h lowest95.8286 AED
24h Price movement+2.85%
Start trade with PTHS Perpetual
Sign up to trade